198 related articles for article (PubMed ID: 23376862)
1. Characterization of the liver-draining lymph nodes in mice and their role in mounting regional immunity to HBV.
Zheng M; Yu J; Tian Z
Cell Mol Immunol; 2013 Mar; 10(2):143-50. PubMed ID: 23376862
[TBL] [Abstract][Full Text] [Related]
2. Two lymph nodes draining the mouse liver are the preferential site of DC migration and T cell activation.
Barbier L; Tay SS; McGuffog C; Triccas JA; McCaughan GW; Bowen DG; Bertolino P
J Hepatol; 2012 Aug; 57(2):352-8. PubMed ID: 22542491
[TBL] [Abstract][Full Text] [Related]
3. The differential organogenesis and functionality of two liver-draining lymph nodes in mice.
Yu J; Chen Y; Wu Y; Ye L; Lian Z; Wei H; Sun R; Tian Z
J Autoimmun; 2017 Nov; 84():109-121. PubMed ID: 28886898
[TBL] [Abstract][Full Text] [Related]
4. The doses of plasmid backbone plays a major role in determining the HBV clearance in hydrodynamic injection mouse model.
Wang X; Zhu J; Zhang Y; Li Y; Ma T; Li Q; Xu J; Xu L
Virol J; 2018 May; 15(1):89. PubMed ID: 29783985
[TBL] [Abstract][Full Text] [Related]
5. Liver type I regulatory T cells suppress germinal center formation in HBV-tolerant mice.
Xu L; Yin W; Sun R; Wei H; Tian Z
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16993-8. PubMed ID: 24089450
[TBL] [Abstract][Full Text] [Related]
6. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-15 suppresses hepatitis B virus replication via IFN-β production in a C57BL/6 mouse model.
Yin W; Xu L; Sun R; Wei H; Tian Z
Liver Int; 2012 Sep; 32(8):1306-14. PubMed ID: 22380514
[TBL] [Abstract][Full Text] [Related]
8. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
[TBL] [Abstract][Full Text] [Related]
9. NK Cells Help Induce Anti-Hepatitis B Virus CD8+ T Cell Immunity in Mice.
Zheng M; Sun R; Wei H; Tian Z
J Immunol; 2016 May; 196(10):4122-31. PubMed ID: 27183639
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo.
Zhu W; Wu C; Deng W; Pei R; Wang Y; Cao L; Qin B; Lu M; Chen X
PLoS One; 2012; 7(9):e45146. PubMed ID: 23024803
[TBL] [Abstract][Full Text] [Related]
11. Localization of CD8+ cells specific for hepatitis B virus surface protein in the liver of immunized mice.
Qu D; Lanier G; Yuan ZH; Wen YM; Howard CR; Ahmed R
J Med Virol; 2008 Feb; 80(2):225-32. PubMed ID: 18098130
[TBL] [Abstract][Full Text] [Related]
12. Individual variation in and lateral asymmetry of mouse epididymal draining lymph nodes.
Peng J; Li H; Yang S; Zhang X; Li PZ; Nie X; Zhang L; Zhang Z
Am J Reprod Immunol; 2023 Apr; 89(4):e13678. PubMed ID: 36648083
[TBL] [Abstract][Full Text] [Related]
13. γδT cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance.
Kong X; Sun R; Chen Y; Wei H; Tian Z
J Immunol; 2014 Aug; 193(4):1645-53. PubMed ID: 25015833
[TBL] [Abstract][Full Text] [Related]
14. Kupffer cell-derived IL-10 plays a key role in maintaining humoral immune tolerance in hepatitis B virus-persistent mice.
Xu L; Yin W; Sun R; Wei H; Tian Z
Hepatology; 2014 Feb; 59(2):443-52. PubMed ID: 23929689
[TBL] [Abstract][Full Text] [Related]
15. A mouse model with age-dependent immune response and immune-tolerance for HBV infection.
Yi X; Yuan Y; Li N; Yi L; Wang C; Qi Y; Gong L; Liu G; Kong X
Vaccine; 2018 Feb; 36(6):794-801. PubMed ID: 29306503
[TBL] [Abstract][Full Text] [Related]
16. Activation of TNF-α-AID axis and co-inhibitory signals in coordination with Th1-type immunity in a mouse model recapitulating hepatitis B.
Matsumoto T; Takahashi K; Inuzuka T; Kim SK; Kurosaki T; Kawakami S; Chiba T; Seno H; Marusawa H
Antiviral Res; 2017 Mar; 139():138-145. PubMed ID: 28063995
[TBL] [Abstract][Full Text] [Related]
17. IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse models.
Shen Z; Liu J; Wu J; Zhu Y; Li G; Wang J; Luo M; Deng Q; Zhang J; Xie Y
Theranostics; 2019; 9(13):3798-3811. PubMed ID: 31281514
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous or Prior Activation of Intrahepatic Type I Interferon Signaling Leads to Hepatitis B Virus Persistence in a Mouse Model.
Zou S; Du Y; Huang S; Chen M; Yang X; Li S; Chen Y; Han M; Li J; Yu Q; Littwitz-Salomon E; Huang H; Trilling M; Liu S; Pei R; Liu J; Wang B; Zheng X; Lu M; Dittmer U; Sun S; Yang D; Wu J
J Virol; 2021 Nov; 95(24):e0003421. PubMed ID: 34550772
[TBL] [Abstract][Full Text] [Related]
19. The dose of HBV genome contained plasmid has a great impact on HBV persistence in hydrodynamic injection mouse model.
Li L; Li S; Zhou Y; Yang L; Zhou D; Yang Y; Lu M; Yang D; Song J
Virol J; 2017 Oct; 14(1):205. PubMed ID: 29070073
[TBL] [Abstract][Full Text] [Related]
20. [Study on the differences of two mouse models of hepatitis B virus infection by transduction with rAAV8-1. 3HBV].
Wang G; Dong XY; Tian WH; Yu CJ; Zheng G; Gao J; Wang GJ; Wei GC; Zhou YS; Wu XB
Bing Du Xue Bao; 2012 Sep; 28(5):541-7. PubMed ID: 23233931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
